After breast conserving surgery, standard treatment in early-stage breast cancer is adjuvant radiotherapy and endocrine treatment.
Standard treatment for metastatic colorectal cancer (mCRC) is combination bevacizumab and fluorouracil-based chemotherapy.
Men who have a localized prostate biopsy Gleason 9-10 with definitive local therapy face worse outcomes.
An elevated c-reactive protein level is associated with poor prognosis in treated patients with prostate cancer.
Docetaxel and 5-fluorouracil as first-line treatment for patients with advanced gastric cancer.
Veliparib combined with oral cyclophosphamide showed promising clinical activity in BRCA-mutant solid tumors.
The FDA has approved Imbruvica (ibrutinib) for the treatment of previously treated patients with Waldenström's macroglobulinemia.
Multidisciplinary cancer team meetings need to systematically consider treatment of patients with comorbidity.
Nimotuzumab has shown promising efficacy for high grade glioma.
For mammography, there has been an increase in biopsies with diagnoses of invasive carcinoma and ductal carcinoma in situ (DCIS).
Researchers have identified certain prognostic factors for survival in patients with Ewing's sarcoma.
Neutrophil-lymphocyte ratio (NLR) change is a potential biomarker for survival in advanced pancreatic cancer.
Prostate biopsies that combine magnetic resonance imaging (MRI) technology with ultrasound give men better information.
Many women with breast cancer lack basic knowledge about their disease, such as their cancer stage and other characteristics
Smoking increases risks for side effects and recurrence in patients being treated for prostate cancer.
Health sector prices explain much of difference between U.S. and other high-spending countries.
Millions signing up for Medicaid to comply with federal health care law.
Almost 80% of doctors in the United States have switched from paper to electronic health records.
Most physicians believe that doctors order too many medical tests, yet half admit to doing so themselves in response to a patient who insists, a new survey shows.
Several modifiable risk factors can cut chronic disease deaths over the next 15 years.
Caucasian women overestimate their risk of breast cancer while African American and Hispanic women underestimate their risk, according to research presented at BCS 2013.
A survey presented at BCS 2013 has found a number of factors that cause rural US women to avoid breast cancer screening.
The benefit of perioperative MRI for women with ductal carcinoma in situ (DCIS) is "uncertain," found a study presented during BCS 2013.
ChemotherapyAdvisor.com Editorial Board member Dr. Edith Perez of the Mayo Clinic, Jacksonville, FL, recommends high impact abstracts at the Breast Cancer Symposium 2013.
Women who underwent radiation for ductal carcinoma in situ do not face an increased risk of cardiovascular disease, found a study presented at BCS 2013.
Sign Up for Free e-newsletters
Cancer Therapy Advisor Articles
- European Society for Medical Oncology (ESMO) Renal Cell Carcinoma Practice Guidelines
- Current and Emerging Therapies for Bone Metastatic Castration-Resistant Prostate Cancer
- Prognostic Factors for Survival in Ewing's Sarcoma Identified
- Surveillance Until Rituximab Retreatment Does Not Increase Anxiety in Non-Hodgkin Lymphoma
- Black Women Disproportionately Affected by Early-Stage Breast Cancer
- Is Ageism Affecting Patients with Prostate Cancer?
- Radiotherapy in Older Women with Early-Stage Breast Cancer after Conserving Treatment
- Continuation or Reintroduction of Bevacizumab Improves Outcomes in Colorectal Cancer
- Gleason Score 9-10 vs. Gleason 8 Associated with Worse Outcomes
- Elevated C-Reactive Protein Linked with Poor Prognosis in Prostate Cancer
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|